Cantor Fitzgerald has reiterated a “Neutral” rating for Centene (CNC) with a price target of $41.00, indicating no change from its previous assessment. This decision aligns with recent diverse analyst ratings, ranging from “Overweight” to “Equal-Weight” with varying price targets, and comes as Centene, a managed care organization, continues to focus on government-sponsored healthcare plans serving 22 million medical members. Wall Street analysts currently hold an average “Hold” recommendation for CNC, with an average target price of $46.10, suggesting an upside from its current price.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Centene (CNC) Analyst Rating Reiterated as Neutral by Cantor Fit
Cantor Fitzgerald has reiterated a “Neutral” rating for Centene (CNC) with a price target of $41.00, indicating no change from its previous assessment. This decision aligns with recent diverse analyst ratings, ranging from “Overweight” to “Equal-Weight” with varying price targets, and comes as Centene, a managed care organization, continues to focus on government-sponsored healthcare plans serving 22 million medical members. Wall Street analysts currently hold an average “Hold” recommendation for CNC, with an average target price of $46.10, suggesting an upside from its current price.